Embecta Corp. (EMBCV)
NASDAQ: EMBCV
· Real-Time Price · USD
33.33
-3.43 (-9.33%)
At close: Apr 01, 2022, 6:00 AM
Company Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes.
Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes.
The company primarily sells its products to wholesalers and distributors in the United States and internationally.
Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey.
Embecta Corp.

Country | United States |
IPO Date | Mar 21, 2022 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 2,029 |
CEO | n/a |
Contact Details
Address: 1 Becton Drive Franklin Lakes, New Jersey United States | |
Website | https://www.embecta.com |
Stock Details
Ticker Symbol | EMBCV |
Exchange | NASDAQ |
Fiscal Year | October - September |
Reporting Currency | USD |
CIK Code | 0001872789 |
CUSIP Number | n/a |
ISIN Number | n/a |
Employer ID | 87-1583942 |
SIC Code | 3841 |
Key Executives
No executives data available.Latest SEC Filings
Date | Type | Title |
---|---|---|
Aug 14, 2025 | SCHEDULE 13G/A | [Amend] Filing |
Aug 11, 2025 | 4 | Filing |
Aug 08, 2025 | 10-Q | Quarterly Report |
Aug 08, 2025 | 8-K | Current Report |
Jul 29, 2025 | SCHEDULE 13G/A | [Amend] Filing |
Jul 18, 2025 | SCHEDULE 13G/A | [Amend] Filing |
May 30, 2025 | SD | Filing |
May 23, 2025 | 4 | Filing |
May 22, 2025 | 8-K | Current Report |
May 15, 2025 | SCHEDULE 13G/A | [Amend] Filing |